dc.contributor.author
Thiele, Felix
dc.contributor.author
Schau, Franziska
dc.contributor.author
Rogasch, Julian M. M.
dc.contributor.author
Wetz, Christoph
dc.contributor.author
Bluemel, Stephanie
dc.contributor.author
Brenner, Winfried
dc.contributor.author
Amthauer, Holger
dc.contributor.author
Lange, Catharina
dc.contributor.author
Schatka, Imke
dc.date.accessioned
2025-08-12T11:11:27Z
dc.date.available
2025-08-12T11:11:27Z
dc.identifier.uri
https://refubium.fu-berlin.de/handle/fub188/48669
dc.identifier.uri
http://dx.doi.org/10.17169/refubium-48393
dc.description.abstract
Background The aims of this study were to establish a normal database (NDB) for semiquantification of dopamine transporter (DAT) single-photon emission computed tomography (SPECT) with [I-123]FP-CIT on a cadmium zinc telluride (CZT) camera, test the preexisting NaI-derived NDB for use in CZT scans, and compare the diagnostic findings in subjects imaged with a CZT scanner with either the preexisting NaI-based NDB or our newly defined CZT NDB.Methods The sample comprised 73 subjects with clinically uncertain parkinsonian syndrome (PS) who prospectively underwent [I-123]FP-CIT SPECT on a CZT camera according to standard guidelines with identical acquisition and reconstruction protocols (DaTQUANT). Two experienced readers visually assessed the images and binarized the subjects into "non-neurodegenerative PS" and "neurodegenerative PS". Twenty-five subjects from the "non-neurodegenerative PS" subgroup were randomly selected to establish a CZT NDB. The remaining 48 subjects were defined as "test group". DaTQUANT was used to determine the specific binding ratio (SBR). For the test group, SBR values were transformed to z-scores for the putamen utilizing both the CZT NDB and the manufacturer-provided NaI-based NDB (GE NDB). A predefined fixed cut-off of -2 was used for dichotomization of z-scores to classify neurodegenerative and non-neurodegenerative PS. Performance of semiquantification using the two NDB to identify subjects with neurodegenerative PS was assessed in comparison with the visual rating. Furthermore, a randomized head-to-head comparison of both detector systems was performed semiquantitatively in a subset of 32 out of all 73 subjects.Results Compared to the visual rating as reference, semiquantification based on the dedicated CZT NDB led to fewer discordant ratings than the GE NDB in CZT scans (3 vs. 8 out of 48 subjects). This can be attributed to the putaminal z-scores being consistently higher with the GE NDB on a CZT camera (median absolute difference of 1.68), suggesting an optimal cut-off of -0.5 for the GE NDB instead of -2.0. Average binding ratios and z-scores were significantly lower in CZT compared to NaI data.Conclusions Use of a dedicated, CZT-derived NDB is recommended in [I-123]FP-CIT SPECT with a CZT camera since it improves agreement between semiquantification and visual assessment.
en
dc.rights.uri
https://creativecommons.org/licenses/by/4.0/
dc.subject
Dopamine transporter
en
dc.subject
Normal database
en
dc.subject.ddc
600 Technik, Medizin, angewandte Wissenschaften::610 Medizin und Gesundheit::610 Medizin und Gesundheit
dc.title
Same same but different: dopamine transporter SPECT on scanners with CZT vs. NaI detectors
dc.type
Wissenschaftlicher Artikel
dcterms.bibliographicCitation.articlenumber
24
dcterms.bibliographicCitation.doi
10.1186/s13550-023-00973-8
dcterms.bibliographicCitation.journaltitle
EJNMMI Research
dcterms.bibliographicCitation.number
1
dcterms.bibliographicCitation.originalpublishername
Springer Nature
dcterms.bibliographicCitation.volume
13
refubium.affiliation
Charité - Universitätsmedizin Berlin
refubium.funding
Springer Nature DEAL
refubium.resourceType.isindependentpub
no
dcterms.accessRights.openaire
open access
dcterms.bibliographicCitation.pmid
36949290
dcterms.isPartOf.eissn
2191-219X